Deciphera Pharmaceuticals | SC TO-C: Written communication relating to an issuer or third party tender offer
Apr 30 09:10 ET
Deciphera Pharmaceuticals | SC14D9C: Written communication by the subject company relating to a third party tender offer
Apr 30 06:12 ET
Deciphera Pharmaceuticals | SC14D9C: Written communication by the subject company relating to a third party tender offer
Apr 29 17:29 ET
Deciphera Pharmaceuticals | SC14D9C: Written communication by the subject company relating to a third party tender offer
Apr 29 17:25 ET
Deciphera Pharmaceuticals | 8-K: Current report
Apr 29 07:18 ET
Deciphera Pharmaceuticals | ARS: Annual Report to Security Holders
Apr 25 16:47 ET
Deciphera Pharmaceuticals | DEFA14A: Others
Apr 25 16:42 ET
Deciphera Pharmaceuticals | DEF 14A: Definitive information statements
Apr 25 07:15 ET
Deciphera Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Brightstar Associates LLC
Apr 24 16:34 ET
Deciphera Pharmaceuticals | PRER14A: Preliminary revised proxy soliciting materials
Apr 22 07:15 ET
Deciphera Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 11 07:14 ET
Deciphera Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sherman Matthew L
Feb 20 16:14 ET
Deciphera Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kelly Thomas Patrick
Feb 20 16:12 ET
Deciphera Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Pitman Jama
Feb 20 16:12 ET
Deciphera Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Martin Daniel C.
Feb 20 16:10 ET
Deciphera Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Dhanak Dashyant
Feb 20 16:10 ET
Deciphera Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Hoerter Steven L.
Feb 20 16:10 ET
Deciphera Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Redmile Group, LLC(9.9%),Jeremy C. Green(9.9%), etc.
Feb 14 16:28 ET
Deciphera Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BRAIDWELL LP(2.92%),BRAIDWELL MANAGEMENT LLC(2.92%), etc.
Feb 14 16:13 ET
Deciphera Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(6.49%),Steven Boyd(6.49%)
Feb 14 15:30 ET
No Data
No Data